与子宫内膜异位症相关的非持久性内分泌干扰化学物质的混合物
Junjie Ao1, Wenting Zhu2, Wen Jiang3
1Ministry of Education-Shanghai Key Laboratory of Children's Environmental Health, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China.
Ecotoxicology and environmental safety
|October 10, 2024
概括
暴露于非持久性内分泌干扰化学物质 (EDC),包括酸盐和双,与更高的子宫内膜异位症风险有关. 这项研究强调了潜在的公共卫生策略,以预防子宫内膜异位症.
科学领域:
- 环境健康 环境健康
- 生殖毒理学 生殖毒理学
- 流行病学 流行病学
背景情况:
- 非持久性内分泌干扰化学物质 (EDC) 已被公认为具有生殖毒性.
- 虽然单次EDC暴露与子宫内膜异位症有关,但混合暴露的数据仍然有限.
- 子宫内膜异位症在全球影响着大量女性,需要对其病因因素进行研究.
研究的目的:
- 调查暴露于非持久性EDC (酸盐和双) 混合物和子宫内膜异位症风险之间的关联.
- 确定有助于子宫内膜异位症风险的特定EDC.
- 探索不同类型的EDC与子宫内膜异位症相关的潜在协同相互作用.
主要方法:
- 一项基于医院的病例控制研究,涉及中国的238例子宫内膜异位症病例和296例控制 (2014-2018).
- 在尿样中测量了17种非持久性EDC (酸盐和双).
- 统计建模使用后勤回归用于单个EDC分析和贝叶斯核机器回归 (BKMR),基于量子的g计算 (q-gcomp) 和主要组件分析 (PCA) 进行混合效应.
主要成果:
- 单个和混合模型都表明,酸盐和双与子宫内膜异位症的风险增加有关 (混合效应:调整后几率比 (aOR) =1.44,1.22-1.70).
- 双甲 (BPA) 和二2-乙基) 甲酸盐 (DEHP) 的代谢物被确定为这种关联的主要贡献者.
- 在双和酸盐之间观察到显著的协同相互作用.
结论:
- 不持久的EDC,特别是酸盐和双,与子宫内膜异位症的风险增加有关.
- 这些发现表明,对多种EDC的联合暴露可能比单个暴露带来更大的风险.
- 需要进一步的研究来阐明潜在的机制,对公共卫生干预和子宫内膜异位症预防策略的潜在影响.
相关概念视频
Oogenesis
63.5K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.5K
Disorders of the Female Reproductive System
333
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
333
Hormonal Regulation of the Menstrual Cycle
310
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
310
Teratogenicity
2.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K
The Endocrine System
244
The endocrine system is an extensive network of glands – organs or tissues in the body that create chemicals that control many bodily functions, that secrete hormones, which are chemical messengers that play essential roles in regulating various bodily functions. These hormones are secreted into the bloodstream and travel throughout the body. They require specific receptors to convey signals to cells possessing these corresponding receptors. This complex signaling mechanism ensures that...
244


